Found "Public health policy": 1,132 results
Sort by
Relevance

Doctor Shortage Likely to Worsen With Health Law

RIVERSIDE, Calif. — In the Inland Empire, an economically depressed region in Southern California, President Obama’s health care law is expected to extend insurance coverage to more than 300,000 people by 2014. But coverage will not necessarily translate into care: Local health experts doubt there w

Header English

Research Projects Close Research Projects Open Research Projects Research Focus Area S P E E

The use of comparative effectiveness research to inform policy decisions on the inclusion of bevacizumab for the treatment of macular diseases in Thailand’s pharmaceutical benefit package

Abstract: There is increasing impetus to use pharmaceutical interventions, ie, ranibizumab or bevacizumab, for the treatment of particular macular diseases. This paper describes the evidence and decision-making of the National List of Essential Medicines Committee that recently announced the inclusi

Economic Analysis of Border Control Policies during COVID-19 Pandemic: A Modelling Study to Inform Cross-Border Travel Policy between Singapore and Thailand

With countries progressing towards high COVID-19 vaccination rates, strategies for border reopening are required. This study focuses on Thailand and Singapore, two countries that share significant tourism visitation, to illustrate a framework for optimizing COVID-19 testing and quarantine policies f

Footer English

© Copyright - HITAP All Rights Reserved. Health Intervention and Technology Assessment Program Foundation Head Office : 88/22 Moo 4, 6th Building, 6th Floor, Department of Health, Ministry of Public Health, Tiwanon Road, Taladkwan Subdistrict, Muang Nonthaburi Distr

Vietnam Country Visit

( 11- 16 November 2013) Health Intervention and Technology Assessment Program (HITAP) researchers and the program leader, Dr. Yot Teerwattananon, made a scoping visit to Vietnam in November 2013. The purpose of the scoping visit was to evaluate the current status of Health Technology Assessment (HTA

Summary: Prince Mahidol Award Conference (PMAC) 2026 Side Meeting on “Antimicrobial Resistance (AMR) in An Ageing World: Policy Challenges and Equity Implications”

Acknowledgements This report was prepared by Dr. Shiela Marie Selisana and Ms. Thitipanchaya Panya from the Health Intervention and Technology Assessment Program Foundation (HITAP) and reviewed by Ms. Saudamini Vishwanath Dabak. The authors are grateful to Dr. Zin Nwe Win for her invaluable as

Dr. Nishanta Sharma

Dr. Nishanta Sharma is a quantitative researcher at HITAP Thailand, currently leading a project that assesses the environmental and economic impacts of low-value healthcare services using input-output analysis, as well as exploring the nexus between climate and epidemiology. He holds a PhD in Development and Sustainability from the Asian Institute

Health Cost of Modifiable Risk Factors in Thailand Phase 2

Diseases are caused by a range of risk factors, some of which are modifiable risk factors. Understanding the health cost burden associated with each modifiable risk factor can provide valuable insights for the health system, such as helping prioritize public health interventions that target the most harmful risk factors or designing programs that c

Evaluation of the Gavi Health Systems Strengthening Support to the Democratic People’s Republic of Korea

The Government of the Democratic People’s Republic of Korea (DPR Korea) was one of the first countries to successfully apply for Gavi, the Vaccine Alliance’s (Gavi) new funding window on health systems strengthening (HSS) in 2006 and was subsequently awarded a second Gavi HSS grant in 2014. The Heal
10 / Page